Argo Blockchain
ARBK
Strategy
MSTR
BTCS Inc
BTCS
Canaan
CAN
Bit Origin
BTOG
US Stock MarketDetailed Quotes
LXRX Lexicon Pharmaceuticals
- 0.785
- +0.044+5.88%
Close Feb 14 16:00 ET
- 0.805
- +0.020+2.56%
Post 19:46 ET
283.74MMarket Cap-1.06P/E (TTM)
0.827High0.750Low2.60MVolume0.751Open0.741Pre Close2.03MTurnover1.43%Turnover RatioLossP/E (Static)361.49MShares2.82952wk High1.59P/B143.01MFloat Cap0.62052wk Low--Dividend TTM182.20MShs Float344.750Historical High--Div YieldTTM10.37%Amplitude0.620Historical Low0.781Avg Price1Lot Size
About Lexicon Pharmaceuticals Company
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Company Profile
SymbolLXRX
Company NameLexicon Pharmaceuticals
Listing DateApr 7, 2000
Issue Price22.00
Founded1995
CEODr. Michael Exton, PhD
MarketNASDAQ
Employees285
Fiscal Year Ends12-31
Address2445 Technology Forest Boulevard,11th floor
CityThe Woodlands
ProvinceTexas
CountryUnited States of America
Zip Code77381-1160
Phone1-281-863-3000
Websitehttp://www.lexpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Michael Exton, PhD
- Chief Executive Officer and Director
- --
- Thomas A. Garner
- Senior Vice President and Chief Commercial Officer
- --
- Scott M. Coiante
- Senior Vice President and Chief Financial Officer
- --
- Dr. Craig B. Granowitz, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.53M
- Kristen L. Alexander
- Vice President, Finance and Accounting and Principal Accounting Officer
- --
- Dr. Kenneth B. Kassler-Taub, M.D.
- Senior Vice President, Regulatory and Quality Assurance
- --
- Brian T. Crum
- Senior Vice President and General Counsel
- 1.42M
- Dr. Alan J. Main,PhD
- Executive Vice President, Innovation and Chemical Sciences
- 1.39M
- Wendy E. McDermott
- Vice President, Human Resources
- --
- Raymond Debbane
- Non-Executive Chairman of the Board
- 127.82K
- Ivan H. Cheung
- Director
- --
- Dr. Judith L. Swain,M.D.
- Independent Director
- 104.96K
- Dr. Samuel L. Barker,PhD
- Independent Director
- 117.46K
- Diane E. Sullivan
- Independent Director
- 176.42K
- Christopher J. Sobecki
- Independent Director
- 89.96K
- Philippe J. Amouyal
- Independent Director
- 100.52K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.